bosentan anhydrous has been researched along with 8-epi-prostaglandin f2alpha in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, MH; Irwin, MG; Lei, S; Liu, HM; Liu, KX; Liu, Y; Xia, Z | 1 |
1 other study(ies) available for bosentan anhydrous and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
Bosentan affects 15-F2t-isoprostane adverse effects on postischemic rat hearts.
Topics: Animals; Bosentan; Creatine Kinase; Dinoprost; Endothelin Receptor Antagonists; Endothelin-1; Heart; Isoprostanes; Male; Models, Animal; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Sulfonamides | 2011 |